vs
礼蓝动物保健（ELAN）与MANITOWOC CO INC（MTW）财务数据对比。点击上方公司名可切换其他公司
礼蓝动物保健的季度营收约是MANITOWOC CO INC的1.7倍（$1.1B vs $677.1M），MANITOWOC CO INC净利率更高（1.0% vs -24.1%，领先25.2%），MANITOWOC CO INC同比增速更快（13.6% vs 12.2%），MANITOWOC CO INC自由现金流更多（$78.3M vs $46.0M），过去两年MANITOWOC CO INC的营收复合增速更高（16.9% vs -2.6%）
礼蓝动物保健是一家美国动物保健制药企业，专注于生产宠物及家畜用药品与疫苗。该公司原为礼来公司旗下子公司，2019年完成分拆独立，目前是全球第三大动物保健企业。
马尼托瓦克公司是一家美国工程机械制造企业，创立于1902年，核心产品为起重机械，历史上曾生产商用制冷设备与船舶设备。公司通过全资子公司，围绕Grove、马尼托瓦克、Potain等多个品牌，设计、生产、销售移动式伸缩臂起重机、塔式起重机、履带式起重机等设备，并提供相关售后服务支持。
ELAN vs MTW — 直观对比
营收规模更大
ELAN
是对方的1.7倍
$677.1M
营收增速更快
MTW
高出1.5%
12.2%
净利率更高
MTW
高出25.2%
-24.1%
自由现金流更多
MTW
多$32.3M
$46.0M
两年增速更快
MTW
近两年复合增速
-2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $677.1M |
| 净利润 | $-276.0M | $7.0M |
| 毛利率 | 51.5% | 16.7% |
| 营业利润率 | -22.6% | 3.0% |
| 净利率 | -24.1% | 1.0% |
| 营收同比 | 12.2% | 13.6% |
| 净利润同比 | -3350.0% | -87.7% |
| 每股收益（稀释后） | $-0.55 | $0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELANMTW
| Q4 25 | $1.1B | $677.1M | ||
| Q3 25 | $1.1B | $553.4M | ||
| Q2 25 | $1.2B | $539.5M | ||
| Q1 25 | $1.2B | $470.9M | ||
| Q4 24 | $1.0B | $596.0M | ||
| Q3 24 | $1.0B | $524.8M | ||
| Q2 24 | $1.2B | $562.1M | ||
| Q1 24 | $1.2B | $495.1M |
净利润ELANMTW
| Q4 25 | $-276.0M | $7.0M | ||
| Q3 25 | $-34.0M | $5.0M | ||
| Q2 25 | $11.0M | $1.5M | ||
| Q1 25 | $67.0M | $-6.3M | ||
| Q4 24 | $-8.0M | $56.7M | ||
| Q3 24 | $364.0M | $-7.0M | ||
| Q2 24 | $-50.0M | $1.6M | ||
| Q1 24 | $32.0M | $4.5M |
毛利率ELANMTW
| Q4 25 | 51.5% | 16.7% | ||
| Q3 25 | 53.4% | 18.5% | ||
| Q2 25 | 57.5% | 18.4% | ||
| Q1 25 | 57.3% | 19.1% | ||
| Q4 24 | 50.9% | 16.0% | ||
| Q3 24 | 52.2% | 16.7% | ||
| Q2 24 | 58.2% | 17.7% | ||
| Q1 24 | 57.3% | 18.7% |
营业利润率ELANMTW
| Q4 25 | -22.6% | 3.0% | ||
| Q3 25 | -4.4% | 3.3% | ||
| Q2 25 | 2.0% | 1.8% | ||
| Q1 25 | 5.0% | 1.1% | ||
| Q4 24 | -5.0% | 2.7% | ||
| Q3 24 | 54.3% | 1.4% | ||
| Q2 24 | -2.7% | 2.3% | ||
| Q1 24 | 1.0% | 3.1% |
净利率ELANMTW
| Q4 25 | -24.1% | 1.0% | ||
| Q3 25 | -3.0% | 0.9% | ||
| Q2 25 | 0.9% | 0.3% | ||
| Q1 25 | 5.6% | -1.3% | ||
| Q4 24 | -0.8% | 9.5% | ||
| Q3 24 | 35.3% | -1.3% | ||
| Q2 24 | -4.2% | 0.3% | ||
| Q1 24 | 2.7% | 0.9% |
每股收益（稀释后）ELANMTW
| Q4 25 | $-0.55 | $0.20 | ||
| Q3 25 | $-0.07 | $0.14 | ||
| Q2 25 | $0.02 | $0.04 | ||
| Q1 25 | $0.13 | $-0.18 | ||
| Q4 24 | $-0.01 | $1.60 | ||
| Q3 24 | $0.73 | $-0.20 | ||
| Q2 24 | $-0.10 | $0.04 | ||
| Q1 24 | $0.06 | $0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $545.0M | $77.3M |
| 总债务越低越好 | $3.9B | $447.1M |
| 股东权益账面价值 | $6.5B | $695.2M |
| 总资产 | $13.4B | $1.8B |
| 负债/权益比越低杠杆越低 | 0.60× | 0.64× |
8季度趋势，按日历期对齐
现金及短期投资ELANMTW
| Q4 25 | $545.0M | $77.3M | ||
| Q3 25 | $505.0M | $39.7M | ||
| Q2 25 | $539.0M | $32.9M | ||
| Q1 25 | $487.0M | $41.4M | ||
| Q4 24 | $468.0M | $48.0M | ||
| Q3 24 | $490.0M | $22.9M | ||
| Q2 24 | $416.0M | $38.1M | ||
| Q1 24 | $345.0M | $31.5M |
总债务ELANMTW
| Q4 25 | $3.9B | $447.1M | ||
| Q3 25 | $4.0B | $479.9M | ||
| Q2 25 | $4.1B | $459.8M | ||
| Q1 25 | $4.4B | $381.4M | ||
| Q4 24 | $4.3B | $377.1M | ||
| Q3 24 | $4.4B | $426.7M | ||
| Q2 24 | $5.7B | $406.3M | ||
| Q1 24 | $5.8B | $372.7M |
股东权益ELANMTW
| Q4 25 | $6.5B | $695.2M | ||
| Q3 25 | $6.7B | $682.7M | ||
| Q2 25 | $6.8B | $681.3M | ||
| Q1 25 | $6.4B | $651.6M | ||
| Q4 24 | $6.1B | $640.1M | ||
| Q3 24 | $6.5B | $607.6M | ||
| Q2 24 | $5.9B | $592.3M | ||
| Q1 24 | $6.1B | $596.0M |
总资产ELANMTW
| Q4 25 | $13.4B | $1.8B | ||
| Q3 25 | $13.6B | $1.9B | ||
| Q2 25 | $13.7B | $1.9B | ||
| Q1 25 | $12.9B | $1.8B | ||
| Q4 24 | $12.6B | $1.7B | ||
| Q3 24 | $13.3B | $1.8B | ||
| Q2 24 | $13.8B | $1.7B | ||
| Q1 24 | $14.0B | $1.8B |
负债/权益比ELANMTW
| Q4 25 | 0.60× | 0.64× | ||
| Q3 25 | 0.59× | 0.70× | ||
| Q2 25 | 0.61× | 0.67× | ||
| Q1 25 | 0.69× | 0.59× | ||
| Q4 24 | 0.70× | 0.59× | ||
| Q3 24 | 0.67× | 0.70× | ||
| Q2 24 | 0.96× | 0.69× | ||
| Q1 24 | 0.95× | 0.63× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $108.0M | $91.1M |
| 自由现金流经营现金流 - 资本支出 | $46.0M | $78.3M |
| 自由现金流率自由现金流/营收 | 4.0% | 11.6% |
| 资本支出强度资本支出/营收 | 5.4% | 1.9% |
| 现金转化率经营现金流/净利润 | — | 13.01× |
| 过去12个月自由现金流最近4个季度 | $284.0M | $-15.3M |
8季度趋势，按日历期对齐
经营现金流ELANMTW
| Q4 25 | $108.0M | $91.1M | ||
| Q3 25 | $219.0M | $-14.1M | ||
| Q2 25 | $237.0M | $-67.7M | ||
| Q1 25 | $-4.0M | $12.9M | ||
| Q4 24 | $177.0M | $112.4M | ||
| Q3 24 | $162.0M | $-43.6M | ||
| Q2 24 | $200.0M | $11.0M | ||
| Q1 24 | $2.0M | $-30.6M |
自由现金流ELANMTW
| Q4 25 | $46.0M | $78.3M | ||
| Q3 25 | $127.0M | $-22.0M | ||
| Q2 25 | $180.0M | $-73.7M | ||
| Q1 25 | $-69.0M | $2.1M | ||
| Q4 24 | $130.0M | $101.1M | ||
| Q3 24 | $120.0M | $-52.9M | ||
| Q2 24 | $166.0M | $-1.9M | ||
| Q1 24 | $-22.0M | $-42.8M |
自由现金流率ELANMTW
| Q4 25 | 4.0% | 11.6% | ||
| Q3 25 | 11.2% | -4.0% | ||
| Q2 25 | 14.5% | -13.7% | ||
| Q1 25 | -5.8% | 0.4% | ||
| Q4 24 | 12.7% | 17.0% | ||
| Q3 24 | 11.7% | -10.1% | ||
| Q2 24 | 14.0% | -0.3% | ||
| Q1 24 | -1.8% | -8.6% |
资本支出强度ELANMTW
| Q4 25 | 5.4% | 1.9% | ||
| Q3 25 | 8.1% | 1.4% | ||
| Q2 25 | 4.6% | 1.1% | ||
| Q1 25 | 5.4% | 2.3% | ||
| Q4 24 | 4.6% | 1.9% | ||
| Q3 24 | 4.1% | 1.8% | ||
| Q2 24 | 2.9% | 2.3% | ||
| Q1 24 | 2.0% | 2.5% |
现金转化率ELANMTW
| Q4 25 | — | 13.01× | ||
| Q3 25 | — | -2.82× | ||
| Q2 25 | 21.55× | -45.13× | ||
| Q1 25 | -0.06× | — | ||
| Q4 24 | — | 1.98× | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | — | 6.88× | ||
| Q1 24 | 0.06× | -6.80× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
MTW
| US | $344.5M | 51% |
| Europe | $193.8M | 29% |
| Other Countries | $138.8M | 20% |
